Slimming drugs as a way to tackle addiction
Patients
taking GLP-1 agonists (semaglutide or tirzepatide) to treat diabetes or obesity drink
less alcohol, smoke fewer cigarettes and experience less nicotine cravings –
according to US pre-clinical, observational and early clinical data.